Literature DB >> 9164883

QT interval dispersion in healthy subjects and survivors of sudden cardiac death: circadian variation in a twenty-four-hour assessment.

J Molnar1, J E Rosenthal, J S Weiss, J C Somberg.   

Abstract

Twenty-four-hour acquisition of QT dispersion (QTd) from the Holter and the circadian variation of QTd were evaluated in 20 survivors of sudden cardiac death (SCD), in 20 healthy subjects, and in 14 control patients without a history of cardiac arrest who were age, sex, diagnosis and therapy matched to 14 SCD patients. Computer-assisted QT measurements were performed on 24-hour Holter recordings; each recording was divided into 288 5-minute segments and templates representing the average QRST were generated. QTd was calculated as the difference between QT intervals in leads V1 and V5 for each template on Holter. The 24-hour mean QTd was significantly greater in SCD patients (40 +/- 28 ms) than in healthy subjects (20 +/- 10 ms) and control patients (15 +/- 5 ms) (p <0.05). There was a circadian variation in QTd with greater values at night (0 to 6 A.M.) than at daytime (10 A.M. to 4 P.M.) in healthy subjects (25 +/- 13 vs 15 +/- 8 ms, p <0.001) and control patients (18 +/- 10 vs 12 +/- 4 ms p <0.05), whereas in SCD patients there was no significant difference between night and day values (45 +/- 31 vs 37 +/- 28 ms, p = NS). It is concluded that QTd measured by Holter was greater in SCD patients than in healthy subjects and matched control patients during the entire day. QTd has a clear circadian variation in normal subjects, whereas this variation is blunted in SCD patients. QTd measured on Holter differentiates survivors of cardiac arrest and may be a useful tool for risk stratification.

Entities:  

Mesh:

Year:  1997        PMID: 9164883     DOI: 10.1016/s0002-9149(97)00080-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Reproducibility of QT parameters derived from 24-hour ambulatory ECG recordings in healthy subjects.

Authors:  H Arildsen; E H Christiansen; A K Pedersen; H Mølgaard
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-01       Impact factor: 1.468

2.  Circadian behavior of P-wave duration, P-wave area, and PR interval in healthy subjects.

Authors:  P E Dilaveris; P Färbom; V Batchvarov; A Ghuran; M Malik
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-04       Impact factor: 1.468

3.  Seasonal variability of QT dispersion in healthy young males.

Authors:  Sedat Kose; Kudret Aytemir; Ilknur Can; Atilla Iyisoy; Hurkan Kursaklioglu; Basri Amasyali; Ayhan Kilic; Ersoy Isik; Ali Oto; Ertan Demirtas
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-01       Impact factor: 1.468

4.  Circadian variation in QT dispersion determined from a 12-lead Holter recording: a methodological study of an age- and sex-stratified group of healthy subjects.

Authors:  Stig Hansen; Verner Rasmussen; Klaus Larsen; Christian Torp-Pedersen; Gorm Boje Jensen
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

5.  Circadian and gender effects on repolarization in healthy adults: a study using harmonic regression analysis.

Authors:  Kenneth A Mayuga; Emil Thattassery; Taresh Taneja; Juhana Karha; Haris Subacius; Jeffrey Goldberger; Alan Kadish
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-01       Impact factor: 1.468

6.  Greater insulin resistance indicates decreased diurnal variation in the QT interval in patients with type 2 diabetes.

Authors:  Kotoko Tanaka; Kenji Yodogawa; Takuya Ono; Kazuo Yana; Masaaki Miyamoto; Hirotsugu Atarashi; Takao Kato; Kyoichi Mizuno
Journal:  Heart Vessels       Date:  2013-05-17       Impact factor: 2.037

7.  Modulation of KCNQ1 alternative splicing regulates cardiac IKs and action potential repolarization.

Authors:  Hsiang-Chun Lee; Yoram Rudy; Phd Po-Yuan; Sheng-Hsiung Sheu; Jan-Gowth Chang; Jianmin Cui
Journal:  Heart Rhythm       Date:  2013-04-19       Impact factor: 6.343

8.  Diminazene aceturate improves autonomic modulation in pulmonary hypertension.

Authors:  Katya Rigatto; Karina R Casali; Vinayak Shenoy; Michael J Katovich; Mohan K Raizada
Journal:  Eur J Pharmacol       Date:  2013-05-09       Impact factor: 4.432

9.  Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects.

Authors:  Taegon Hong; Seunghoon Han; Jongtae Lee; Sangil Jeon; Gab-Jin Park; Wan-Su Park; Kyoung Soo Lim; Jae-Yong Chung; Kyung-Sang Yu; Dong-Seok Yim
Journal:  Drug Des Devel Ther       Date:  2015-02-26       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.